CRISPR-Cas9 for Disease Resistant Vines
December 11, 2024 |
Botrytis cinerea, or gray mold, is a major threat to grapevines worldwide. This disease causes substantial losses and diminishes crop quality, both during growth and post-harvest.
As climate change poses more challenges to crops, the need for disease-resistant grape cultivars becomes more urgent. In a new study conducted by researchers from Nanjing Forestry University and Northwest A&F University, researchers made significant progress in using CRISPR-Cas9 gene editing technology to bolster grapevine resistance to B. cinerea.
The researchers looked at how gray mold infects grapevines, from a biotrophic phase (where the pathogen relies on living tissue) to a necrotrophic phase (where it kills the tissue it infects). They were able to identify key genes that govern grape resistance or susceptibility to the pathogen. These findings could open up new avenues for developing grape varieties that can naturally resist the disease without relying on chemical treatments. Using CRISPR-Cas9 technology makes possible the creation of modified grapevines that enhance the plant's ability to fight off gray mold.
For more details, read the news article in NewsWise.
|
You might also like:
- Gene-edited Grapevine Shows Resistance to Downy Mildew
- Scientists Use CRISPR to Produce a 'SuperGrape'
- Gene Editing of Grapes Enhances Aromatic Attributes
Biotech Updates is a weekly newsletter of ISAAA, a not-for-profit organization. It is distributed for free to over 22,000 subscribers worldwide to inform them about the key developments in biosciences, especially in biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
-
See more articles:
-
Gene Editing Supplement (December 11, 2024)
-
Research and Tools
- CRISPR Enhances Resistance of Tomato Against Bacterial Wilt Disease
- Gene Editing and Plant Domestication as Key Tools for Food Security and Facing Climate Change
- Gene Editing Market Value to Reach USD 17.5 B by 2031
- CRISPR-Cas9 for Disease Resistant Vines
-
Read the latest: - Biotech Updates (January 22, 2025)
- Gene Editing Supplement (January 15, 2025)
- Gene Drive Supplement (February 22, 2023)
-
Subscribe to BU: - Share
- Tweet